These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14109898)

  • 41. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Challenge of paediatric compounding to solid dosage forms sachets and hard capsules - Finnish perspective.
    Sivén M; Kovanen S; Siirola O; Hepojoki T; Isokirmo S; Laihanen N; Eränen T; Pellinen J; Juppo AM
    J Pharm Pharmacol; 2017 May; 69(5):593-602. PubMed ID: 27704551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formulation and evaluation of floating tablet of H2-receptor antagonist.
    Kesarla RS; Vora PA; Sridhar BK; Patel G; Omri A
    Drug Dev Ind Pharm; 2015; 41(9):1499-511. PubMed ID: 25243639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of lubricants and colloidal silica during mixing with excipients. I. Its effect on tabletting.
    Lerk CF; Bolhuis GK; Smedema SS
    Pharm Acta Helv; 1977; 52(3):33-9. PubMed ID: 918125
    [No Abstract]   [Full Text] [Related]  

  • 45. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of microcrystalline cellulose prepared from sisal fibers as a tablet excipient: a technical note.
    Bhimte NA; Tayade PT
    AAPS PharmSciTech; 2007 Feb; 8(1):8. PubMed ID: 17408230
    [No Abstract]   [Full Text] [Related]  

  • 49. Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
    Sadeghi M; Hemmati S; Hamishehkar H
    Drug Dev Ind Pharm; 2016 May; 42(5):769-775. PubMed ID: 26275030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of lubricants and colloidal silica during mixing with excipients. II. Its effect on wettability and dissolution velocity.
    Lerk CF; Bolhuis GK
    Pharm Acta Helv; 1977; 52(3):39-44. PubMed ID: 918126
    [No Abstract]   [Full Text] [Related]  

  • 51. Influence of the Punch Head Design on the Physical Quality of Tablets Produced in a Rotary Press.
    Anbalagan P; Sarkar S; Liew CV; Heng PWS
    J Pharm Sci; 2017 Jan; 106(1):356-365. PubMed ID: 27842972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Production and assessing release of imipramine and magnesium from tablets].
    Kasperek R; Zimmer Ł; Szalast-Pietrzak A; Marzec Z; Poleszak E
    Polim Med; 2014; 44(4):247-53. PubMed ID: 25932906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microparticle surface layering through dry coating: impact of moisture content and process parameters on the properties of orally disintegrating tablets.
    Alyami H; Koner J; Dahmash EZ; Bowen J; Terry D; Mohammed AR
    J Pharm Pharmacol; 2017 Jul; 69(7):807-822. PubMed ID: 27696423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride.
    Yamamura T; Ohta T; Taira T; Ogawa Y; Sakai Y; Moribe K; Yamamoto K
    Int J Pharm; 2009 Mar; 370(1-2):1-7. PubMed ID: 19059327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y; Kojima M; Ando S; Nakagami H
    J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The combination of various modes of binding in tablets].
    Hüttenrauch R; Jacob J
    Pharmazie; 1979; 34(9):572. PubMed ID: 542492
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
    Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
    Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
    Odeku OA
    Acta Pharm; 2005 Sep; 55(3):263-76. PubMed ID: 16375837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and Optimization of Fast-Disintegrating Tablet Containing Naratriptan Hydrochloride Using D-Optimal Mixture Design.
    Omar SM; AbdAlla FI; Abdelgawad NM
    AAPS PharmSciTech; 2018 Aug; 19(6):2472-2487. PubMed ID: 29869307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.